TACR1 and cancer: By eliminating the expression of this receptor in cancer cells, due to apoptotic mechanisms, a decrease in the number of these cells has been reported and it is also known that in tumor cells the application of the siRNA TAC1R method decreased the levels of p-EGFR, p-Akt and p-ERK (Figure 1) [5,26,58].